(CAH) Cardinal Health - Ratings and Ratios

Cardinal Health Inc (NYSE:CAH) is a global healthcare services and products company that provides a wide range of solutions to healthcare providers, manufacturers, and patients. With a presence in the US, Canada, Europe, Asia, and beyond, the company operates through two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. Its diversified portfolio includes pharmaceutical distribution, medical supplies, and manufacturing of medical products such as gloves, needles, and wound care solutions.

The companys extensive services include pharmacy management for hospitals, repackaging of generic pharmaceuticals, and supply chain management for healthcare providers. Additionally, Cardinal Health manufactures and distributes radiopharmaceuticals, and provides integrated technology solutions to optimize direct shipments. With a history dating back to 1979, the company has established itself as a leader in the healthcare industry, with a strong presence in the US and a growing global footprint.

From a technical analysis perspective, CAHs stock has shown a strong uptrend, with its current price of $155.25 nearing its 52-week high. The stocks SMA20, SMA50, and SMA200 indicators suggest a bullish trend, with the short-term and long-term moving averages converging. The ATR of 3.24 (2.09%) indicates moderate volatility. Using these technical indicators, we can forecast that CAHs stock may continue to rise in the short term, potentially reaching $165-170, driven by its strong trend and improving momentum.

Fundamentally, Cardinal Healths market capitalization stands at $36.75 billion, with a P/E ratio of 23.99 and a forward P/E of 16.84. The companys return on equity (RoE) is negative, at -50.14, indicating potential challenges in generating profits. However, its diversified business model and strong presence in the healthcare industry may help drive growth. By combining the fundamental data with technical analysis, we can forecast that CAHs stock may experience a correction in the medium term, potentially falling to $140-145, due to its high valuation and negative RoE. Nevertheless, the companys strong industry position and improving trend may help it recover and drive long-term growth.

Overall, Cardinal Health Inc (NYSE:CAH) is a well-established player in the healthcare industry, with a diversified portfolio and strong global presence. While its stock may experience short-term volatility, its long-term prospects appear promising, driven by its improving trend and strong industry position.